Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.46
$0.01753.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 790.70K | 1.65M | 836.90K | 798.70K | 572.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.78M | 3.05M | 1.48M | 1.38M | 1.28M |
| Operating Income | -1.78M | -3.05M | -1.48M | -1.38M | -1.28M |
| Income Before Tax | -1.60M | -3.78M | -2.03M | -1.73M | -1.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.60M | -3.78M | -2.03M | -1.73M | -1.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.60M | -3.78M | -2.03M | -1.73M | -1.64M |
| EBIT | -1.78M | -3.05M | -1.48M | -1.38M | -1.28M |
| EBITDA | -1.78M | -3.05M | -1.48M | -1.38M | -1.28M |
| EPS Basic | -0.33 | -1.59 | -0.97 | -0.83 | -0.82 |
| Normalized Basic EPS | -0.20 | -0.80 | -0.61 | -0.50 | -0.53 |
| EPS Diluted | -0.40 | -1.59 | -0.97 | -0.83 | -0.82 |
| Normalized Diluted EPS | -0.20 | -0.80 | -0.61 | -0.50 | -0.53 |
| Average Basic Shares Outstanding | 4.91M | 2.38M | 2.10M | 2.08M | 2.01M |
| Average Diluted Shares Outstanding | 4.91M | 2.38M | 2.10M | 2.08M | 2.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
